QPPV.COM KNOWLEDGE ASSESSMENT

Pharmacovigilance Inspections: Professional Knowledge Assessment

Test your understanding of the concepts covered by Pharmacovigilance Inspections.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which situation is most characteristic of a for-cause pharmacovigilance inspection?

A planned inspection conducted as part of routine oversight An inspection initiated in response to a specific concern such as serious compliance problems or a safety signal An inspection conducted only after a product has been withdrawn An inspection limited to reviewing employee training certificates

Question 2 of 10 A company provides an electronic evidence pack containing many documents but no index, timestamps or explanation of document relevance. What is the principal weakness?

The pack is necessarily invalid because electronic documents cannot be inspected The evidence may be difficult to navigate, interpret and trace to inspection questions The company has provided too much evidence and must delete all operational records Inspectors can assess only documents that are printed

Question 3 of 10 Which response is most appropriate when an interviewee does not know the answer to an inspector's question immediately?

Provide a speculative answer to avoid creating concern Refuse to answer all subsequent questions State that the point will be checked and provide a documented follow-up Ask another interviewee to give an answer without verifying it

Question 4 of 10 A company has a current PSMF, but its index still identifies a former vendor as responsible for a major PV activity. What is the most appropriate interpretation?

The issue is administrative only and has no inspection relevance It may indicate that the PSMF and the implemented governance structure are not aligned The vendor automatically becomes responsible for all MAH obligations The PSMF should be removed from the inspection evidence pack

Question 5 of 10 Which is the strongest example of CAPA effectiveness verification for delayed submissions?

A statement that the responsible manager is satisfied A revised SOP with no evidence of subsequent performance Time-bound KPI trending from defined data sources showing sustained improvement against an acceptance criterion A meeting invitation for a future review

Question 6 of 10 Which evidence most directly demonstrates that the QPPV has effective oversight rather than merely a nominal appointment?

The QPPV's name appearing only on an organisation chart A QPPV CV, documented delegation and contactability arrangements, plus evidence of involvement in safety governance A list of all products marketed by the company without role descriptions A general corporate policy that does not mention pharmacovigilance

Question 7 of 10 Which activity is most directly intended to verify that archived pharmacovigilance records remain usable over time?

Documenting and testing transfer procedures to long-term archives and ensuring records remain searchable Deleting superseded records immediately after a new SOP is approved Restricting all archive access to the QPPV without maintaining access records Keeping only paper copies regardless of the original record format

Question 8 of 10 Which feature is most important when preparing representative ICSR files for an inspection?

Including only the final case narrative and omitting processing history Providing an end-to-end, redacted record showing source, assessment, reporting decision, submission receipt and quality control Selecting only cases with no follow-up activity Removing all medical information to avoid any possible privacy concern

Question 9 of 10 An MAH presents a comprehensive set of SOPs, but inspectors discover that actual case processing routinely differs from those procedures. What concern is most directly raised?

The organisation has too many SOPs The pharmacovigilance system lacks demonstrated operational control The inspection should automatically be classified as pre-authorisation The QPPV should be removed from all governance meetings

Question 10 of 10 What makes a CAPA more likely to satisfy regulatory expectations?

A broad commitment to improve without defined ownership or measures A documented link between the finding, evidence-based root cause, actions, owners, deadlines and effectiveness verification Closure based solely on completion of a training session A target date selected without considering risk or available resources

Pharmacovigilance Inspections: Professional Knowledge Assessment

Cookie Settings